Inspire Medical Systems
INSP

$196.88

0.19%

Market Cap: $5.87B

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Employees: 1,011

Healthcare Surgical & Medical Instruments & Apparatus

0

Funds holding %

of 6,686 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

23% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 97

0.54% less ownership

Funds ownership: 106.94% [Q1] → 106.4% (-0.54%) [Q2]

1% less funds holding

Funds holding: 322 [Q1] → 320 (-2) [Q2]

2% less call options, than puts

Call options by funds: $68.8M | Put options by funds: $70.1M

3% less first-time investments, than exits

New positions opened: 71 | Existing positions closed: 73

38% less capital invested

Capital invested by funds: $6.8B [Q1] → $4.23B (-$2.57B) [Q2]

89% less funds holding in top 10

Funds holding in top 10: 9 [Q1] → 1 (-8) [Q2]

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$170

14%

downside

Avg. target

$216

9%

upside

High target

$260

32%

upside

6 analyst ratings

5 positive

83%

1 neutral

17%

0 negative

0%

Keybanc Brett Fishbin 87% 1-year accuracy 13 / 15 met price target	20%upside $236	Overweight Maintained	7 Aug 2024
RBC Capital Shagun Singh 69% 1-year accuracy 43 / 62 met price target	32%upside $260	Outperform Reiterated	7 Aug 2024
Baird Mike Polark 57% 1-year accuracy 4 / 7 met price target	2%upside $200	Outperform Maintained	7 Aug 2024
Truist Securities Richard Newitter 67% 1-year accuracy 29 / 43 met price target	10%upside $217	Buy Maintained	16 Jul 2024
Morgan Stanley Kallum Titchmarsh 50% 1-year accuracy 1 / 2 met price target	7%upside $210	Overweight Maintained	15 Jul 2024

See Analyst Rankings

Financial journalist opinion

Based on 6 articles about INSP published over the past 30 days

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK , Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance.

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Zacks Investment Research

Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom

Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Clover Health Investments and CareCloud are expected to gain from the GenAI wave.

Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom

Inspire Medical Systems: Inspired, With Improving Risk-Reward (Rating Upgrade)

Inspire Medical Systems has shown impressive growth, become profitable and recently obtained FDA approval for a new device. The company's Inspire system treats sleep apnea with neurostimulation technology, achieving significant sales growth for years now. Trading at around 6 times sales, the company's strong performance, profitability, and growth potential make it an attractive investment.

Inspire Medical Systems: Inspired, With Improving Risk-Reward (Rating Upgrade)

Zacks Investment Research

Why Inspire Medical Systems (INSP) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Inspire Medical Systems (INSP) is a Top Momentum Stock for the Long-Term

Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences

MINNEAPOLIS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Morgan Stanley 22nd Annual Global Healthcare Conference and the Wells Fargo 2024 Healthcare Conference on Wednesday, September 4, 2024.

Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences

Zacks Investment Research

Why Inspire (INSP) Might be Well Poised for a Surge

Inspire (INSP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Why Inspire (INSP) Might be Well Poised for a Surge

Zacks Investment Research

Inspire Medical (INSP) Q2 Earnings Beat, Gross Margin Rises

Inspire Medical (INSP) reports strong second-quarter results, reflecting a 30% revenue increase. Its new technology and expanded U.S. presence promise growth and enhanced patient care.

Inspire Medical (INSP) Q2 Earnings Beat, Gross Margin Rises

Inspire Medical Systems, Inc. (INSP) Q2 2024 Earnings Call Transcript

Inspire Medical Systems, Inc. (INSP) Q2 2024 Earnings Call Transcript

Inspire Medical Systems, Inc. (INSP) Q2 2024 Earnings Call Transcript

Zacks Investment Research

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

Zacks Investment Research

Inspire Medical Systems (INSP) Tops Q2 Earnings Estimates

Inspire Medical Systems (INSP) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to loss of $0.41 per share a year ago.

Inspire Medical Systems (INSP) Tops Q2 Earnings Estimates

See News Rankings